Carregant...

Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1

The soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) has been tested in both animals and humans for anti-angiogenic therapies, e.g., age-related macular degeneration. We hypothesized that adeno-associated viral vector (AAV)-mediated sFLT1 expression could be used to inhibit abnor...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gene Ther
Autors principals: Shen, Fanxia, Mao, Lei, Zhu, Wan, Lawton, Michael T., Pechan, Peter, Colosi, Peter, Wu, Zhijian, Scaria, Abraham, Su, Hua
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4636448/
https://ncbi.nlm.nih.gov/pubmed/26090874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2015.57
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!